期刊文献+

基因治疗性研究的现状及其伦理学思考 被引量:2

Current Status and Ethical Thinking on Gene Therapy Research
下载PDF
导出
摘要 通过对基因治疗性研究的发展状况及现状分析研究,指出基因治疗存在的伦理问题:安全性问题,基因治疗与社会公正及基因治疗的合理性与必要性。并针对这些问题提出了以下解决措施:强化国家和政府理性调控的力度,建立健全安全监督机制,建立相关法律法规,约束基因治疗研究;提高基因治疗技术上的安全性研究;加强科学工作者的伦理责任意识,确保受试者的知情同意权、尊重人的自主性权利、遵守不伤害原则;以公正与公益的原则为出发点,尽可能避免商业因素的影响;强化对基因技术的社会约束。 Based on the development of gene therapy research and the present situation analysis,this paper pointed out the ethical issues of gene therapy,that is,the safety,the rationality and necessity of developing gene therapy.And then put forward the following measures to solve these problems:strengthening the reason of the state and government regulation,establishing and improving the safety supervision mechanism,establishing relevant state laws and regulations,constraints on gene therapy research ; improving the safety of gene therapy technology research ; strengthening ethical responsibility consciousness of scientific workers,ensuring that the subjects' informed consent and respecting their autonomy rights,adhering to the principle of do no harm ; taking the principle of justice and public welfare as the starting point,avoid commercial factors as more as possible; strengthening the social constraints of gene technology.
出处 《中国医学伦理学》 2014年第5期631-633,共3页 Chinese Medical Ethics
基金 南京军区医学科技创新项目(No.09MA085) 江苏省医学人文社会社会科学基金项目(No.JSYRKJ2010-B2-001) 江苏省"六大人才高峰"第六批项目资助计划
关键词 基因治疗 安全性 伦理问题 医疗资源 Gene Therapy Safety Ethical Issues Medical Resources
  • 相关文献

参考文献12

  • 1Aposhian H V. The use of DNA for gene therapy the need, experimental approach, and implications [ J ]. Perspect Bio Med, 1970,14 ( 1 ) : 98-108.
  • 2Friedmann T, Roblin R. Gene therapy for human ge- netic disease [ J ]. Science, 1972,175 (4025) :949-955.
  • 3Wolff J A, Lederberg J. An early history of gene transfer and therapy [ J ]. Human Gene Therapy,1994,5(4) : 469-480.
  • 4Sun M. Cline loses two NIH grants [ J ]. Science, 1981,214(4526) : 1220-1220.
  • 5Sheridan C. Gene therapy finds its niche [ J]. Nat Biotechno1,2011,29 (2) : 121-128.
  • 6Wirth T, Parker N, Yla-Herttuala, S. History of gene therapy[ J]. Gene,2013,525 (2) :162-169.
  • 7Peng Z. Current status of gendicine in China: re- combinant human Ad-p53 agent for treatment of cancers [ J ]. Human Gene Therapy, 2005,16 ( 9 ) : 1016-1027.
  • 8Liang M. Clinical development of oncolytic viruses in China[ J]. Curr Pharm Biotechno1,2012,13 (9) : 1852-1857.
  • 9Melchiorri D, Pani L, Gasparini P, et al. Regulato- ry evaluation of Glybera in Europe-two committees, one mission [ J ]. Nat Rev Drug Discov, 2013,12 (9) :719-719.
  • 10Naldini L. Medicine. A comeback for gene therapy [ J ]. Science,2009,326 (5954): 805-806.

二级参考文献13

  • 1许志伟.面对科技,生命何以自处──论北美生命伦理学[J].复旦学报(社会科学版),1999,41(2):71-83. 被引量:18
  • 2Cavazzana-Calvo M, Hacein-Bey S, de Saint Basil G,et al.Gene therapy of human severe combined immunodeficiency (SCID) X1disease[J]. Science,2000,288:669-672.
  • 3Cavazzana-Calvo M,Thrasher A,Mavilio F, et al.The future of gene therapy Balancing the risks and benefits of clinical trial[J]. Nature,2004,427:779-781.
  • 4Fox JL.US panel advises resumption of gene trials [J]. Nat Biotechnol, 2002,20(11):1068-1069.
  • 5Lehrman S. Virus treatment questioned after gene therapy death[J]. Nature,1999,401:517-518.
  • 6Viscusi WK.The value of a statistical life:a critical review of market estimates throughout the world[J]. J Risk Uncertainty,2003,27:1:5-76.
  • 7Edelstein ML,Abedi MR,Wixon,J.Gene therapy clinical triah worldwide 1989-2004 an overview[J].J G.ene Medicine,2004,6:597-602.
  • 8Thompson,Dennis F.Understanding financial conflicts of interest[J]. New England J Medicine,1993,329:452.
  • 9Orkin,SH,Motulsky AG. Report and recommendations of the panel to assess the NIH investment in research on gene therapy[R]. Washington DC: National Institutes of Health, 1995.
  • 10毛新志.转基因食品的伦理审视[M]武汉:湖北人民出版社,2005.

共引文献4

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部